Rapporto annuale 2007 - Istituto di Ricerche Farmacologiche Mario ...

IRFMN
D'Incalci M., Brunelli D., Marangon E., Simone M., Tavecchio M., Gescher A., Mantovani A.
Modulation of gene transcription by natural products. A viable anticancer strategy? Current
Pharmaceutical Design 2007; 13: 2744-2750.
Di Francesco A.M., Meco D., Torella A.R., Barone G., D'Incalci M., Pisano C., Carminati P.,
Riccardi R. The novel atypical retinoid ST1926 is active in ATRA resistant neuroblastoma cells
acting by a different mechanism. Biochem Pharmacol 2007; 73: 643-655.
Bertele' V., Banzi R., Capasso F., Tafuri G., Trotta F., Apolone G., Garattini S. Haematological
anticancer drugs in Europe: any added value at the time of approval? Eur J Clin Pharmacol
2007; 63: 713-719.
Grassi R., Lombardi G., Reginelli A., Capasso F., Romano F., Floriani I., Colacurci N.
Coccygeal movement: Assessment with dynamic MRI. Eur J Radiol 2007; 61: 473-479.
Torri V., Floriani I., Poli D., European Glaucoma Prevention Study Group (EGPS). Central
corneal thickness in the European Glaucoma Prevention Study. Ophthalmology 2007; 114:
454-459.
Gambacorti Passerini C., Tornaghi L, Marangon E., Franceschino A., Pogliani E., D'Incalci M.,
Zucchetti M. Imatinib concentrantrations in human milk. Blood 2007; 109: 1790
Ruzzo A., Graziano F., Loupakis F., Rulli E., Canestrari E., Santini D., Catalano V., Ficarelli
R., Maltese P., Bisonni R., Masi G., Schiavon G., Giordani P., Giustini L., Falcone A., Tonini
G., Silva R., Mattioli R., Floriani I., Magnani M. Pharmacogenetic profiling in patients with
advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy. J Clin Oncol
2007; 25: 1247-1254.
European Glaucoma Prevention Study Group (EGPS), Torri V., Floriani I., Rulli E., Poli D.
Predictive factors for open-angle glaucoma among patients with ocular hypertension in the
European Glaucoma Prevention Study. Ophthalmology 2007; 114: 3-9.
Grosso F., Jones R.L., Demetri G.D., Judson I.R., Blay J-Y., Le Cesne A., Sanfilippo R., Casieri
P., Collini P., Dileo P., Spreafico C., Stacchiotti S., Tamborini E., Tercero J.C., Jimeno J.,
D'Incalci M., Gronchi A., Fletcher J.A., Pilotti S., Casali P.G. Efficacy of trabectedin
(ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study. Lancet
Oncol 2007; 8: 595-602.
Zangrossi S., Marabese M., Broggini M., Giordano R., D'Erasmo M., Montelatici E., Intini D.,
Neri A., Pesce M., Rebulla P., Lazzari L. Oct-4 expression in adult human differentiated cells
challenges its role as a pure stem cell marker. Stem Cells 2007; 25: 1675-1680.
Martinelli M., Bonezzi K., Riccardi E., Kuhn E., Frapolli R., Zucchetti M., Ryan A.J.,
Taraboletti G., Giavazzi R. Sequence dependent antitumor efficacy of the vascular disrupting
agent ZD6126 in combination with paclitaxel Br J Cancer 2007; 97: 888-894.
Giavazzi R., Bani M.R., Taraboletti G. Tumor-host interaction in the optimization of paclitaxelbased
combination therapies with vascular targeting compounds. Cancer Metastasis Rev 2007;
26: 481-488.
Marabese M., Vikhanskaya F., Broggini M. p73: A chiaroscuro gene in cancer. Eur J Cancer
2007; 43: 1361-1372.
29
RAPPORTO ATTIVITA’ 2007